A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
Active, not recruiting · NCT06649695 · Registry updated 2026-07-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, proteostasis deficiencies | Active, not recruiting | Phase 2 | 2026-07-20 | NCT06649695 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| European Myeloma Network B.V. | 9 |
| Janssen Research & Development, LLC | 188 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Limoges | Limoges | France | 42 |
| Fondazione I.R.C.C.S Policlinico "San Matteo" | Pavia | Italy | 1 |
| General Hospital of Athens "Alexandra" | Athens | Greece | 2 |
| South Australia Health | Adelaide | Australia | 1 |
| UMC Utrecht | Utrecht | Netherlands | 42 |
| University Hospital Essen | Essen | Germany | 17 |
| University Hospital Heidelberg | Heidelberg | Germany | 18 |
| University Hospital Würzburg | Würzburg | Germany | 4 |
| Westmead Hospital | Sydney | Australia | 8 |